Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2021-12-02
Original market date: See footnote 1
1978-12-31
Product name:
CYSTO-CONRAY II
Description:
SINGLE USE
DIN:
00397466
Product Monograph/Veterinary Labelling:
Date:
2021-11-26
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
LIEBEL-FLARSHEIM COMPANY LLC
8800 Durant Rd.
Raleigh
North Carolina
United States
27616
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Urethral
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
36:68.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V08AA04 IOTALAMIC ACID
Active ingredient group (AIG) number:See footnote5
0102763004
| Active ingredient(s) | Strength |
|---|---|
| IOTHALAMATE MEGLUMINE | 172 MG / ML |